Lee Fairlie to HIV
This is a "connection" page, showing publications Lee Fairlie has written about HIV.
Connection Strength
0,774
-
Lamivudine monotherapy in children and adolescents: The devil is in the detail. S Afr Med J. 2017 Nov 27; 107(12):1055-1057.
Score: 0,476
-
Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review. PLoS One. 2021; 16(3):e0248423.
Score: 0,150
-
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):201-204.
Score: 0,037
-
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus. Clin Infect Dis. 2020 10 23; 71(7):e105-e114.
Score: 0,036
-
Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc. 2018 12; 21(12):e25215.
Score: 0,032
-
Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa. Pediatr Infect Dis J. 2015 Feb; 34(2):175-9.
Score: 0,024
-
Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis. Antivir Ther. 2011; 16(3):417-21.
Score: 0,018